Scientist 1 / 2, AAV Capsid Library - Gene Therapy Research
Location:San Rafael, California
Overview
With accelerated review underway in the United States and Europe for our Hemophilia A drug, a second gene therapy program entering the clinic for PKU patients, and a third program in late research for Hereditary Angioedema, BioMarin continues to pioneer innovative approaches to treating rare diseases. Our commitment to gene therapy is further underscored by having developed the first and largest gene therapy manufacturing facility in the world. The scientific possibilities and the hope we offer to patients with rare diseases is enormous.
BioMarin is a midsize biotechnology company with a market cap of approximately 18 billion. Over the course of our 22 year history we have successfully launched 7 drugs for the treatment of rare diseases. Our success is due to our scientific rigor and our ability to leverage multiple therapeutic modalities. BioMarin is based in the San Francisco Bay Area and offers a comprehensive relocation program.
Success Profile
Check out the traits we’re looking for and see if you have the right mix.
- Decision Making
- Influence
- Collaboration
- Agility
- Leadership
- Intellectual Curiosity
Our CULTURE
- Patient Focused
- Results Oriented
- Pioneering Science
- Cross Functional Collaboration
- Willing to try new ways to look at problems
Benefits
-
Healthcare
-
Medical
-
Dental
-
Vision
-
Health & Wellness Programs
-
401(k)/Retirement plans